Search Orphan Drug Designations and Approvals
-
Generic Name: | Interferon alfa-2a (recombinant) |
---|---|
Date Designated: | 10/27/1989 |
Orphan Designation: | For use in combination with fluorouracil for the treatment of esophageal carcinoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Hoffmann-La Roche, Inc. 340 Kingsland Street Nutley, New Jersey 07110 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-